Institutional investors purchased a net $78.9 thousand shares of TROV during the quarter ended June 2014, and now own 22.68% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY SMITH BARNEY LLC Bought 100.6 Thousand shares of Trovagene Inc